Data from the TCGA, GTEx, and TARGET databases indicated that NCAPG2 expression is significantly higher in tumor samples compared to that in normal samples in 31 tumor types: ACC, ALL, BRCA, BLCA, COAD/READ, CHOL, CESC, COAD, GBM, GBMLGG, ESCA, KIRC, KIPAN,HNSC, LUAD, LGG, LAML, LUSC, LIHC, PAAD, PRAD, READ, PCPG, STAD, STES, SKCM, OV, TGCT, UCS, UCEC, and WT (Fig. 1C). Here, NCAPG2 is linked to acute lymphoblastic leukemia.